XML 21 R11.htm IDEA: XBRL DOCUMENT v3.7.0.1
Goodwill and Intangible Assets
9 Months Ended
Mar. 31, 2017
Goodwill And Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets

(5)

GOODWILL AND INTANGIBLE ASSETS

Goodwill

The Company has recorded goodwill of $315.0 from the acquisitions of Assurex that was completed on August 31, 2016, Sividon that was completed on May 31, 2016, Privatklinik Dr. Robert Schindlbeck GmbH & Co. KG (the “Clinic”) that was completed on February 27, 2015, Crescendo Bioscience, Inc. that was completed on February 28, 2014 and Rules-Based Medicine, Inc. that was completed on May 31, 2011.  Of this goodwill, $249.9 relates to the Company’s diagnostic segment and $65.1 relates to the other segment.  The following summarizes changes to the goodwill balance for the nine months ended March 31, 2017:

 

 

 

Carrying

amount

 

Beginning balance July 1, 2016

 

$

195.3

 

Acquisitions (see note 2)

 

 

119.7

 

Adjustments to acquisitions (see note 2)

 

 

0.8

 

Translation adjustments

 

 

(0.8

)

Ending balance March 31, 2017

 

$

315.0

 

 

Intangible Assets

Intangible assets primarily consist of amortizable assets of purchased licenses and technologies, customer relationships, and trade names as well as non-amortizable intangible assets of in-process technologies and research and development.  The following summarizes the amounts reported as intangible assets:

 

 

 

Gross

 

 

 

 

 

 

 

 

 

 

 

Carrying

 

 

Accumulated

 

 

 

 

 

 

 

Amount

 

 

Amortization

 

 

Net

 

At March 31, 2017:

 

 

 

 

 

 

 

 

 

 

 

 

Purchased licenses and technologies

 

$

523.9

 

 

$

(52.0

)

 

$

471.9

 

Customer relationships

 

 

4.7

 

 

 

(2.7

)

 

 

2.0

 

Trademarks

 

 

3.0

 

 

 

(0.8

)

 

 

2.2

 

Total amortized intangible assets

 

 

531.6

 

 

 

(55.5

)

 

 

476.1

 

In-process research and development

 

 

22.0

 

 

 

 

 

 

22.0

 

Total unamortized intangible assets

 

 

22.0

 

 

 

 

 

 

22.0

 

Total intangible assets

 

$

553.6

 

 

$

(55.5

)

 

$

498.1

 

 

 

 

Gross

 

 

 

 

 

 

 

 

 

 

 

Carrying

 

 

Accumulated

 

 

 

 

 

 

 

Amount

 

 

Amortization

 

 

Net

 

At June 30, 2016:

 

 

 

 

 

 

 

 

 

 

 

 

Purchased licenses and technologies

 

$

228.7

 

 

$

(28.5

)

 

$

200.2

 

Customer relationships

 

 

4.7

 

 

 

(2.4

)

 

 

2.3

 

Trademarks

 

 

3.0

 

 

 

(0.6

)

 

 

2.4

 

Total amortized intangible assets

 

 

236.4

 

 

 

(31.5

)

 

 

204.9

 

In-process research and development

 

 

22.6

 

 

 

 

 

 

22.6

 

Total unamortized intangible assets

 

 

22.6

 

 

 

 

 

 

22.6

 

Total intangible assets

 

$

259.0

 

 

$

(31.5

)

 

$

227.5

 

 

The Company recorded amortization expense during the respective periods for these intangible assets as follows:

 

 

 

Three months ended

 

 

Nine months ended

 

 

 

March 31,

 

 

March 31,

 

 

 

2017

 

 

2016

 

 

2017

 

 

2016

 

Amortization of intangible assets

 

$

9.2

 

 

$

3.1

 

 

$

24.0

 

 

$

9.4